CPRT vs TRAW · P/E 19, rev $3.51B vs rev $2.8M
Copart Inc (CPRT) versus Traws Pharma Inc (TRAW) — a side-by-side from cached financials, not a winner call.
Copart Inc (CPRT) is a specialty business services company listed on US.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Latest reported CPRT revenue for 2026-04-30 was $3.51B. Net income was $1.16B. Revenue was up 54.3% from 2026-01-31 to 2026-04-30. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
CPRT currently screens at market cap $28.66B and trailing P/E 19.2. TRAW currently screens at market cap $12.1M.
Not investment advice. Open the CPRT and TRAW stock pages for the full models.
Not investment advice.